Tinelli, Michela, John, White and Manfrin, Andrea ORCID: 0000-0003-3457-9981
(2018)
Novel pharmacist-led intervention secures the minimally important difference (MID) in Asthma Control Test (ACT) score: better outcomes for patients and the healthcare provider.
BMJ Open Respiratory Research, 2018
(5).
e000322 1-9.
Manfrin, Andrea ORCID: 0000-0003-3457-9981 and Tinelli, Michela
(2017)
Le traitement contre l’asthme meilleur et moins coûteux grâce aux pharmacies.
pharmaJournal, 13
.
pp. 22-24.
Manfrin, Andrea ORCID: 0000-0003-3457-9981, Tinelli, Michela, Thomas, Trudy and Krska, Janet
(2017)
A cluster randomised control trial to evaluate the effectiveness and cost-effectiveness of the Italian medicines use review (I-MUR) for asthma patients.
BMC Health Services Research, 17
.
Manfrin, Andrea ORCID: 0000-0003-3457-9981, Knapp, Martin, Cicchetti, Americo, Mandelli, Andrea and Tinelli, Michela
(2018)
VP164 Applying health technology assessment to pharmacy: the Italian-Medicine-Use-Review-Health Technology Assessment.
In: HATi, 2018, Rome Italy.
Manfrin, Andrea ORCID: 0000-0003-3457-9981 and Tinelli, Michela
(2017)
The clinical, utility and economic benefits of securing minimal important difference in asthma control test using a novel tool: the a.b.o.v.e. asthma (achieving-better-outcomes-and-value-for- everybody-in-asthma).
In: British Thoracic Society (BTS) Winter Meeting, 6-8 December 2017, London.